Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aleglitazar plus metformin vs placebo plus metformin in type 2 diabetes mellitus
CTR20140085Phase 3Suspended
- Sponsor
- Roche
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aleglitazar in type 2 diabetes mellitus (T2DM), sponsored by Roche. Started May 2014; status: suspended.
02
Drugs
aleglitazar
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20140085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140085.